Hepatic failure: current problems of treatment


Cite item

Full Text

Abstract

References

  1. Bilir В. М., Gu'mette D., Karrer F. et al. Hepatocyte transplantation in acute liver failure. Liver transplant. 2000; 6: 32-40.
  2. Hoofnagle J. H., Carithers R. L., Shapiro С et al. Fulminant hepatic failure: Summary of a workshop. Hepatology, 1995; 21: 240-252.
  3. Redeker A. G, Yamahiro H. S. Controlled trial of exchangetransfusion therapy in fulminant hepatitis. Lancet 1973; 1: 3- 6.
  4. Lai E. C, Fan S. Т., Lo С. М, et al. Hepatic resection for hepatocellular carcinoma. An. audit of 344 patients. Am. Surg. 1995; 221 (3): 291-298.
  5. Lui W. Y, Chiu S. Т., Chiu J. H. et al. Evaluation of a simplified staging system for prognosis of hepatocellular carcinoma.J. Formos. Med. Assoc. 1999; 98 (4): 248-453.
  6. Ellis A. J., Wendon J. A., Williams R. Sub-clinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000; 32: 536-541.
  7. Kelly J. H., Sussman N. L. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure.ASAIO J. 1994; 40: 83-85.
  8. Гальперин Э. И., Семендяева Е. Н., Неклюдова Е. А. Недостаточность печени. М.: Медицина; 1978.
  9. Шерлок Ш., Дули Дж. Заболевания печени и желчных путей. М.: Медицина; 1999.
  10. Kanai N., Jeffrey L., Piatt M. D, Xenotransplantation of the liver. Clin. Liver Dis. 2000; 3: 1234-1256.
  11. ВЫ А. Т. Medical therapy of brain edema in fulminant hepatic failure. Hepatology 2000; 32 (3): 230-246.
  12. Kettyle W. M., Arky R. A. Endocrine pathophysiology. Philadelphia, New York: Lippincott-Raven; 1998.
  13. Каплан Е. Я., Эпштейн И. М. Влияние перекисного окисления липидов на функциональное состояние гепатоцита. В кн.: Применение 02 под повышенным давлением в медицине. М.; 1971. 216-218.
  14. Максимова И. Е., Фокина Т. С, Самецкая Н. Б. и др. Оценка эффективности применения гипербарической оксигенации в гепатологии. Там же. 125-126.
  15. Ponikvar R., Buturovic J., Cizman M. Hyperbaric oxygenation, plasma exchange, and hemodialysis for treatment of acute liver failure in a 3-year-old child. Artif. Organs 1998; 22 (11): 952- 957.
  16. Краковский А. И., Подлужный В. И., Федюшкина Н. А. Применима ли гипербарическая оксигенация при механической желтухе и острой печеночной недостаточности? Хирургия 1980; 1: 60-64.
  17. Лужников Е. А., Гольдфарб Ю. С, Мусселиус С. Г. Детоксикационная терапия. СПб, 2000.
  18. Лимфосорбция / Панченков Р. Т., Выренков Ю. Е., Ярема И. В. и др. М.; 1982.
  19. Брискин Б. С, Яценко А. А., Филонов А. В. и др. Лимфосорбция при лечении больных с печеночной недостаточностью и желтухой. Вестн. хир. 1986; 1: 40-45.
  20. McChesney L. P., Pagan E. A., Rowell D. L. et al. Extracorporeal liver perfusion. Lancet 1999; 353: 120-121.
  21. Gazzard B. G., Portmann В., Weston M. J. et al. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Ibid. 1974; 1: 1301-1307.
  22. Gimson A. E. S., Braude S., Mellon P. J. et al. Earlier charcoal haemoperfusion in fulminant hepatic failure. Ibid. 1982; 2: 681-683.
  23. O'Grady J., Gimson A. E. S., O'Brien С J. et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-1192.
  24. Trey C, Burns D. G., Sanders S. J. Treatment of hepatic coma by exchange blood transfusion. N. Engl. J. Med. 1966; 274: 473-481.
  25. Jander S., Bischoff J. Treatment of amanita phalloides poisoning: I. Retrospective evaluation of plasmapheresis in 21 patients. [In Process Citation]. Ther. Apher. 2000; 4 (4): 303- 307.
  26. Kondrup J., Almdal Т., Vilstrup H. et al. High volume plasma exchange in fulminant hepatic failure. Int. J. Artif. Organs. 1992; 15:669-676.
  27. Iwai H., Nagaki M., Naito T. et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit. Care Med. 1998; 26: 873-876.
  28. Шиманко И. И., Мусселиус С. Г. Острая печеночно-почечная недостаточность. М.: Медицина; 1993.
  29. Cordoba J., Blei А. Т., Mujais S. Determinants of ammonia clearance by hemodialysis. Artif. Organs 1996; 20: 800-803.
  30. De Groot G. H., Schalm S. W., Schicht I. et al. Comparison of large-pore membrane haemodialysis and cross-dialysis id acute hepatic insufficiency in pigs. Eur. J. Clin. Invest. 1983; 13: 65-71.
  31. Kiley J. E., Pender J. C, Welch H. F. Ammonia intoxication treated by hemodialysis. N. Engl. J. Med. 1958; 259: 1156- 1161.
  32. Opolon J. D., Nusinovici V., Granger A. et al. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 1978; 19: 787-793.
  33. Silk D. В., Trewby P. N., Chase R. A. et al. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet 1977; 2: 1-3.
  34. Matsubara S. Combination of plasma exchange and continuous hemofiltration as temporary metabolic support for patients with acute liver failure. Artif. Organs 1994; 18 (5): 363-366.
  35. Denis J., Opolon P., Delorme M. L. et al. Long-term extra-corporeal assistance by continuous haemofiltration during fulminant hepatic failure. Gastroenterol. Clin. Biol. 1979; 3: 337- 348.
  36. Yosiba M., Inoue K., Sekiyama K. et al. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif. Organs 1996; 20: 1169-1172.
  37. Abouna G. M., Serrou В., Beohmig H. G. et al. Long-term hepatic support by intermittent multi-species liver perfusions. Lancet 1970; 2: 391-396.
  38. Foley D. P., Vittimberga F. J., Quarfordt S. H. et al. Biliary secretion of extracorporeal porcine livers with single and dual vessel perfusion. Transplantation 1999; 68: 362-368.
  39. Chari R. S., Collins В., Magee J. С et al. Brief report: Treatment of hepatic failure with ex vivo pigliver perfusion followed by liver transplantation. N. Engl. J. Med. 1994; 331: 234-237.
  40. Fox I. J. Cell liver transplantation. Gastroenterology 1999; 45: 7-12.
  41. Абдуллаев Э. Г., Корухов Н. Ю., Писаревский А. А. и др. Опыт применения консервированных ксеногепатоцитов в комплексном лечении больных желтухами. Вестн. хир. 1991; 4: 101-103.
  42. Morsiani E., Puviani А. С, Brogli M. et al. Sperimentazione in vitro di tin nuovo modello di bioreattore a flusso radiate contenente epatociti isolati. Ann. Ital. Chir. 2000; 71: 337-345.
  43. Tanigushi S., Cooper D. К. С Clinical xenotransplantation - a brief re view of the world experience. In: Cooper D. K. S.,Kemp E., Piatt J. L. et al., eds. Xenotransplantation. Berlin: Springer Verlag; 1997. 776-784.
  44. Шумаков В. И., Онищенко Н. А. Лечение печеночной недостаточности методами трансплантации и экстракорпорального подключения печени и других тканей: (биологические и клинические аспекты). М.; 1994.
  45. Desille M., Corcos L., L'Helgoualc'h A. et al. Detoxifying activity in pig livers and hepatocytes intended for xenotherpy. Transplantation 1999; 10: 1437-1443.
  46. Suh К. S., Lilja H., Kamohara Y. Bioartifical liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth- associated transcription factors. J. Surg. Res. 1999; 85 (2): 243-250.
  47. Kobayashi N., Miyazaki M., Fukaya K. Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure. Transplantation 2000; 4 (2): 202-207.
  48. Strom S. C, Fisher R. A., Thompson M. T. et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Ibid. 1997; 63 (3): 559-569.
  49. Lake J. Hepatocyte transplantation. N. Engl. J. Med. 1998; 338: 1463-1465.
  50. Watanabe F. D., Million С J., Hewitt W. R. et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase 1 clinical trial. Ann. Surg. 1997; 225: 484- 491.
  51. Tomiya Т., Hayashi S., Yanase M. et al. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer. Semin. Oncol. 1997; 24 (6): 6-17.
  52. Hui Т., Rozga J., Demetriou A. A. Bioartificial liver treatment for patients with fulminant hepatic failure: The Cedars-Sinai Medical Center experience. In: Arroyo V., Bosch J., Bruguera M. et al. eds. Treatment of liiver diseases. Barcelona: Masson; 1999. 137-150.
  53. Sussman N. L., Gisalon G., Conlin С A. et al. The hepatix extracorporeal liver assist device; initial clinical experience. Artif. Organs 1994; 18: 390-396.
  54. Chen S. C, Hewitt W. R., Eguchi S. et al. Prolonged survival in anhepatic pigs treated with a bioartificial liver. Surg. Forum. 1996; 47: 161-163.
  55. Blei A. T. Brain edema and intracranial hypertension: a focus for the use of liver support systems. Artif. Organs 1997; 21: 1182-1184.
  56. Makowka L., Rotstein L. E., Folk R. E. et al. Allogeneic and xenogeneic hepatocyte transplantation in expermental liver failure. Transplantation 1980; 30: 429-435.
  57. Sandrin M. S., Fodor W. L., Mouhtouris E. et al. Enzymating remo delling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement mediated cytolysis. Nat. Med. 1995; 1: 1261 - 1267.
  58. Bader A., Knop E., Boker A. et al. A novel bioreactor design for in vitro reconstruction of in vivo liver characteristics. Artif. Organs 1995; 19: 347-352.
  59. Bonatti H., Muiesan P., Connolly S. et al. Liver transplantation for acute liver failure in children under 1 year of age. Transplant. Proc. 1997; 29: 434-443.
  60. Hattori H, Higuchi Y., Tsuji M. et al. Living-related liver transplanlation and neurological outcome in children with fulminant hepatic failure. Transplantation 1998; 65: 686-692.
  61. Harper A. M., Rosendale J. D., McBride M. A. et al. The UNOSOPTN waiting list and donor registry. Clin. Transplant. 1998; 3: 73-90.
  62. Гулак П. В. Гепатоцит: функционально-метаболические свойства. М.: 1985.
  63. Calne R. Y. Observation on experimental and clinical liver transplantation. In: Clinical transplantation. New York: 1972. 347-353.
  64. Bernal W., Wendon J., Rela M. et al. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27: 1050-1055.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2003 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies